Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EMR | GEV |
|---|---|---|
| Price | $155.03 | $951.57 |
| Change today | ▲ 0.28% | ▼ 0.03% |
| Market cap | $86.47B | $253.44B |
| Return, 3 months | +10.0% | -10.0% |
| Return, year to date | +18.1% | +45.9% |
| Return, 1 year | +19.4% | +51.6% |
| P/E (TTM) | 33.9 | 27.3 |
| P/B | 4.2 | 21.2 |
| P/E percentile vs own 5y | 78th | 13th |
| Dividend yield | 1.41% | 0.21% |
| Revenue growth (YoY, latest qtr) | +7.0% | +21.9% |
| Net profit growth (YoY) | +22.5% | +31.9% |
| Gross margin | 53.2% | 20.2% |
| Operating margin | 20.7% | 4.4% |
| Net margin | 13.8% | 23.0% |
| Return on equity | 12.8% | 91.5% |
| Analyst target vs. price | +10.4% | +31.3% |
| Analyst buy share | 69% | 89% |
| RSI (14) | 55 | 49 |
| 30-day volatility | 24.1% | 47.5% |
| Max drawdown, 1 year | -23.4% | -25.5% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.